Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2016

01-08-2016 | Short Research Report

Impact of clinical pharmacy services in a short stay unit of a hospital emergency department in Qatar

Authors: Hani Abdelaziz, Rasha Al Anany, Ashraf Elmalik, Mohammad Saad, Kirti Prabhu, Haleema Al-Tamimi, Salem Abu Salah, Peter Cameron

Published in: International Journal of Clinical Pharmacy | Issue 4/2016

Login to get access

Abstract

Background The presence of a clinical pharmacist in a hospital’s Emergency Department (ED) is important to decrease the potential for medication errors. To our knowledge, no previous studies have been conducted to evaluate the impact of implementing clinical pharmacy services in the ED in Qatar. Objective To characterize the contributions of clinical pharmacists in a short stay unit of ED in order to implement and scale-up the service to all ED areas in the future. Methods A retrospective study conducted for 7 months in the ED of Hamad General Hospital, Qatar. The intervention recommendations were made by clinical pharmacists to the physician in charge during medical rounds. Results A total of 824 documented pharmacist recommendations were analyzed. The interventions included the following: Providing information to the physician (24.4 %) and recommending medication discontinuation (22.0 %), dose adjustment (19.3 %), medication addition (16.0 %), changes in frequency of medications (7.6 %), medication resumption (5.7 %), and patient education (5.0 %). Conclusion Clinical pharmacists in the ED studied play an important role in patient care.
Literature
1.
go back to reference Cobaugh J, Schneider S. Medication use in the emergency department: why are we placing patients at risk? Am J Health Syst Pharm. 2005;62(17):1832–3.CrossRefPubMed Cobaugh J, Schneider S. Medication use in the emergency department: why are we placing patients at risk? Am J Health Syst Pharm. 2005;62(17):1832–3.CrossRefPubMed
2.
go back to reference Seigel TA, McGillicuddy DC, Barkin AZ, Rosen CL. Morbidity and mortality conference in emergency medicine. J Emerg Med. 2010;38(4):507–11.CrossRefPubMed Seigel TA, McGillicuddy DC, Barkin AZ, Rosen CL. Morbidity and mortality conference in emergency medicine. J Emerg Med. 2010;38(4):507–11.CrossRefPubMed
3.
go back to reference Kripalani S, Roumie CL, Dalal AK, Cawthon C, Businger A, Eden SK, et al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157(1):1–10.CrossRefPubMedPubMedCentral Kripalani S, Roumie CL, Dalal AK, Cawthon C, Businger A, Eden SK, et al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157(1):1–10.CrossRefPubMedPubMedCentral
4.
go back to reference Elenbaas RM, Waeckerle JF, McNabney WK. The clinical pharmacist in emergency medicine. Am J Hosp Pharm. 1977;34(8):843–6.PubMed Elenbaas RM, Waeckerle JF, McNabney WK. The clinical pharmacist in emergency medicine. Am J Hosp Pharm. 1977;34(8):843–6.PubMed
5.
go back to reference Nana B, Lee-Such S, Allen G. Initiation of an emergency department pharmacy program during economically challenging times. Am J Health Syst Pharm. 2012;69(19):1682+. Health Reference Center Academic. Web. 18 May 2015. Nana B, Lee-Such S, Allen G. Initiation of an emergency department pharmacy program during economically challenging times. Am J Health Syst Pharm. 2012;69(19):1682+. Health Reference Center Academic. Web. 18 May 2015.
6.
go back to reference Mutnick AH, Sterba KJ, Peroutka JA, Sloan NE, Beltz EA, Sorenson MK. Cost savings and avoidance from clinical interventions. Am J Health Syst Pharm. 1997;54(4):392–6.PubMed Mutnick AH, Sterba KJ, Peroutka JA, Sloan NE, Beltz EA, Sorenson MK. Cost savings and avoidance from clinical interventions. Am J Health Syst Pharm. 1997;54(4):392–6.PubMed
7.
go back to reference McMullin ST, Hennenfent JA, Ritchie DJ, Hueyw Y, Lonergan TP, Schaiff RA, et al. A prospective, randomized trial to assess the cost impact of pharmacist initiated interventions. Arch Intern Med. 1999;159(19):2306–9.CrossRefPubMed McMullin ST, Hennenfent JA, Ritchie DJ, Hueyw Y, Lonergan TP, Schaiff RA, et al. A prospective, randomized trial to assess the cost impact of pharmacist initiated interventions. Arch Intern Med. 1999;159(19):2306–9.CrossRefPubMed
8.
go back to reference Otoum S. Relationship between availability of emergency department-based clinical pharmacy services and incidence of medication errors in emergency departments: a systematic review. Gulf Med J. 2013;2(1):3–9. Otoum S. Relationship between availability of emergency department-based clinical pharmacy services and incidence of medication errors in emergency departments: a systematic review. Gulf Med J. 2013;2(1):3–9.
9.
go back to reference Lada P, Delgado G. Documentation of pharmacists’ interventions in an emergency department and associated cost avoidance. Am J Health Syst Pharm. 2007;64(1):63–8.CrossRefPubMed Lada P, Delgado G. Documentation of pharmacists’ interventions in an emergency department and associated cost avoidance. Am J Health Syst Pharm. 2007;64(1):63–8.CrossRefPubMed
10.
go back to reference Hajjar ER, Hanlon JT, Sloane RJ, Lindblad CI, Pieper CF, Ruby CM, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc. 2005;53(9):1518–23.CrossRefPubMed Hajjar ER, Hanlon JT, Sloane RJ, Lindblad CI, Pieper CF, Ruby CM, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc. 2005;53(9):1518–23.CrossRefPubMed
11.
go back to reference Mekonnen AB, Yesuf EA, Odegard PS, Wega SS. Implementing ward based clinical pharmacy services in an Ethiopian University Hospital. Pharm Pract. 2013;11(1):51–7.CrossRef Mekonnen AB, Yesuf EA, Odegard PS, Wega SS. Implementing ward based clinical pharmacy services in an Ethiopian University Hospital. Pharm Pract. 2013;11(1):51–7.CrossRef
12.
go back to reference Cesarz JL, Steffenhagen AL, Svenson J, Hamedani AG. Emergency department discharge prescription interventions by emergency medicine pharmacists. Ann Emerg Med. 2013;61(2):209–14.CrossRefPubMed Cesarz JL, Steffenhagen AL, Svenson J, Hamedani AG. Emergency department discharge prescription interventions by emergency medicine pharmacists. Ann Emerg Med. 2013;61(2):209–14.CrossRefPubMed
13.
go back to reference Baker SN, Acquisto NM, Ashley ED, Fairbanks RJ, Beamish SE, Haas CE. Pharmacist-managed antimicrobial stewardship program for patients discharged from the emergency department. J Pharm Pract. 2012;25(2):190–4.CrossRefPubMed Baker SN, Acquisto NM, Ashley ED, Fairbanks RJ, Beamish SE, Haas CE. Pharmacist-managed antimicrobial stewardship program for patients discharged from the emergency department. J Pharm Pract. 2012;25(2):190–4.CrossRefPubMed
14.
go back to reference Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and Adverse drug events in the Intensive Care Unit. JAMA. 2000;283(10):267–70. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and Adverse drug events in the Intensive Care Unit. JAMA. 2000;283(10):267–70.
Metadata
Title
Impact of clinical pharmacy services in a short stay unit of a hospital emergency department in Qatar
Authors
Hani Abdelaziz
Rasha Al Anany
Ashraf Elmalik
Mohammad Saad
Kirti Prabhu
Haleema Al-Tamimi
Salem Abu Salah
Peter Cameron
Publication date
01-08-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-016-0290-9

Other articles of this Issue 4/2016

International Journal of Clinical Pharmacy 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.